- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02672579
Study of Kids Itch Severity (SKIS) (SKIS)
August 11, 2018 updated by: Suephy Chen, MD, Emory University
Study of Kids Itch Severity (SKIS): "Validation and Mobilization of Pediatric Pruritus Outcome Instruments"
This purpose of this study is to validate two measures of chronic itching in kids: itch severity (ItchyQuant) and the impact on their quality of life (ItchyQoL).
Study Overview
Status
Completed
Conditions
Detailed Description
There are many diseases that affect children where the primary symptom is pruritus.
This study aims to validate an age appropriate pediatric version of the ItchyQoL, a pruritus-specific quality of life instrument, and the ItchyQuant, a self-reported itch severity scale, to better understand how pruritus affects the pediatric population.
These instruments will comprehensively capture the severity and impact of pruritus in children.
The physicians want to explore the opportunity to integrate patient-reported outcome measures (PROM) as a patient-reported tool in the ambulatory setting.
Study Type
Observational
Enrollment (Actual)
312
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children between the ages of 4 and 17 who have chronic pruritus (for 6 weeks or longer).
The information detailed below is reflective of the pediatric population which is the primary focus of this study though the parents and clinicians will also complete surveys.
Description
Inclusion Criteria:
- Female and male patients between the ages of 4 and 17 (parents and clinicians will be older than 18 years, both male and female)
- Informed consent/assent signed and dated by the patient/parent
- Willingness and ability for the patient to commit to all follow-up visits/phone calls for the duration of the study
Exclusion Criteria:
- Inability to speak or read English
- Any other disabilities that would prevent them from completing a survey
- Unwillingness or inability for the patient to commit to all follow-up visits/phone calls for the duration of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Children 4-7 years
Pediatric subjects between the ages of 4 and 7 who have had pruritus for 6 weeks or longer will complete surveys to assess the severity of pruritus.
|
|
Children 8-17 years
Pediatric subjects between the ages of 8 and 17 who have had pruritus for 6 weeks or longer will complete surveys to assess the severity of pruritus.
|
|
Parents
Parents of pediatric subjects between the ages of 4-17 years with chronic pruritus (for 6 weeks or longer) will complete surveys to assess their perception of their child's severity of pruritus.
|
|
Clinicians
Clinicians treating pediatric subjects between the ages of 4-17 years with chronic pruritus (for 6 weeks or longer) will complete surveys to assess their perception of the child's severity of pruritus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ItchyQoL (TotsItchyQoL) test-retest reliability
Time Frame: Baseline
|
Subjects in the 4-7 year age group will complete the TotsItchyQoL® questionnaire.
This questionnaire has a total of 16 items with cartoons accompanying each question.
The interviewer will ask the subjects questions to rate how pruritus affected their quality of life (QOL).
The test-retest reliability will be assessed by analyzing the recorded responses to assess improvement, no change, or worsening of their pruritus.
|
Baseline
|
|
ItchyQoL (KidsItchyQoL) test-retest reliability
Time Frame: Baseline
|
Subjects in the 8-17 year age group will complete the KidsItchyQoL® questionnaire.
This is a 27-item questionnaire where the subjects are asked to rate how pruritus affected their quality of life (QOL).
The test-retest reliability will be assessed by analyzing the recorded responses to assess improvement, no change, or worsening of their pruritus.
|
Baseline
|
|
ItchyQoL (TotsItchyQoL) validity
Time Frame: Baseline
|
Subjects in the 4-7 year age group will complete the TotsItchyQoL® questionnaire.
There are a total of 16 items with cartoons accompanying each question.
The subjects will be asked to rate the severity of their pruritus and the responses will be recorded.
Each response will be scored and the scores will be compared across pruritus severity; mild,moderate or severe; to assess the validity of the questionnaire.
|
Baseline
|
|
ItchyQoL (KidsItchyQoL) validity
Time Frame: Baseline
|
Subjects in the 8-17 year age group will complete the TotsItchyQoL® questionnaire.
There are a total of 16 items with cartoons accompanying each question.
The subjects will be asked to rate the severity of their pruritus and the responses will be recorded.
Each response will be scored and the scores will be compared across pruritus severity; mild,moderate or severe; to assess the validity of the questionnaire.
|
Baseline
|
|
Psychometric properties of the ItchyQuant
Time Frame: Baseline
|
Age-appropriate ItchyQuant will be administered as follows; subjects 4-5 years will use the modified 3-point ItchyQuant, for subjects 6-7 years, the 3-point and 5-point ItchyQuant and for ages 8 and older, the traditional non-cartoon version of the numeric rating scale (NRS) will be administered.
The parent and clinician will also be asked to rate their perceived itch severity on a full-cartoon version of the ItchyQuant.
The ItchyQuant is a 10-point numeric rating scale to rate itch severity.
The items are scored from 0-10, where 0=no itch and 10= worst imaginable itch.
The validity of the ItchyQuant will be assessed by comparing the responses.
|
Baseline
|
|
ItchyQoL (TotsItchyQoL) test-retest reliability
Time Frame: 1 hour from baseline
|
Subjects in the 4-7 year age group will complete the TotsItchyQoL® questionnaire.
This questionnaire has a total of 16 items with cartoons accompanying each question.
The interviewer will ask the subjects questions to rate how pruritus affected their quality of life (QOL).
The test-retest reliability will be assessed by analyzing the recorded responses to assess improvement, no change, or worsening of their pruritus.
|
1 hour from baseline
|
|
ItchyQoL (TotsItchyQoL) test-retest reliability
Time Frame: 6 months
|
Subjects in the 4-7 year age group will complete the TotsItchyQoL® questionnaire.
This questionnaire has a total of 16 items with cartoons accompanying each question.
The interviewer will ask the subjects questions to rate how pruritus affected their quality of life (QOL).
The test-retest reliability will be assessed by analyzing the recorded responses to assess improvement, no change, or worsening of their pruritus.
|
6 months
|
|
ItchyQoL (KidsItchyQoL) test-retest reliability
Time Frame: 7 days
|
Subjects in the 8-17 year age group will complete the KidsItchyQoL® questionnaire.
This is a 27-item questionnaire where the subjects are asked to rate how pruritus affected their quality of life (QOL).
The test-retest reliability will be assessed by analyzing the recorded responses to assess improvement, no change, or worsening of their pruritus.
|
7 days
|
|
ItchyQoL (KidsItchyQoL) test-retest reliability
Time Frame: 6 months
|
Subjects in the 8-17 year age group will complete the KidsItchyQoL® questionnaire.
This is a 27-item questionnaire where the subjects are asked to rate how pruritus affected their quality of life (QOL).
The test-retest reliability will be assessed by analyzing the recorded responses to assess improvement, no change, or worsening of their pruritus.
|
6 months
|
|
ItchyQoL (TotsItchyQoL) validity
Time Frame: 1 hour from baseline
|
Subjects in the 4-7 year age group will complete the TotsItchyQoL® questionnaire.
There are a total of 16 items with cartoons accompanying each question.
The subjects will be asked to rate the severity of their pruritus and the responses will be recorded.
Each response will be scored and the scores will be compared across pruritus severity; mild,moderate or severe; to assess the validity of the questionnaire.
|
1 hour from baseline
|
|
ItchyQoL (TotsItchyQoL) validity
Time Frame: 6 months
|
Subjects in the 4-7 year age group will complete the TotsItchyQoL® questionnaire.
There are a total of 16 items with cartoons accompanying each question.
The subjects will be asked to rate the severity of their pruritus and the responses will be recorded.
Each response will be scored and the scores will be compared across pruritus severity; mild,moderate or severe; to assess the validity of the questionnaire.
|
6 months
|
|
ItchyQoL (KidsItchyQoL) validity
Time Frame: 7 days
|
Subjects in the 8-17 year age group will complete the TotsItchyQoL® questionnaire.
There are a total of 16 items with cartoons accompanying each question.
The subjects will be asked to rate the severity of their pruritus and the responses will be recorded.
Each response will be scored and the scores will be compared across pruritus severity; mild,moderate or severe; to assess the validity of the questionnaire.
|
7 days
|
|
ItchyQoL (KidsItchyQoL) validity
Time Frame: 6 months
|
Subjects in the 8-17 year age group will complete the TotsItchyQoL® questionnaire.
There are a total of 16 items with cartoons accompanying each question.
The subjects will be asked to rate the severity of their pruritus and the responses will be recorded.
Each response will be scored and the scores will be compared across pruritus severity; mild,moderate or severe; to assess the validity of the questionnaire.
|
6 months
|
|
Psychometric properties of the ItchyQuant
Time Frame: 1 week
|
Age-appropriate ItchyQuant will be administered as follows; subjects 4-5 years will use the modified 3-point ItchyQuant, for subjects 6-7 years, the 3-point and 5-point ItchyQuant and for ages 8 and older, the traditional non-cartoon version of the numeric rating scale (NRS) will be administered.
The parent and clinician will also be asked to rate their perceived itch severity on a full-cartoon version of the ItchyQuant.
The ItchyQuant is a 10-point numeric rating scale to rate itch severity.
The items are scored from 0-10, where 0=no itch and 10= worst imaginable itch.
The validity of the ItchyQuant will be assessed by comparing the responses.
|
1 week
|
|
Psychometric properties of the ItchyQuant
Time Frame: 2 weeks
|
Age-appropriate ItchyQuant will be administered as follows; subjects 4-5 years will use the modified 3-point ItchyQuant, for subjects 6-7 years, the 3-point and 5-point ItchyQuant and for ages 8 and older, the traditional non-cartoon version of the numeric rating scale (NRS) will be administered.
The parent and clinician will also be asked to rate their perceived itch severity on a full-cartoon version of the ItchyQuant.
The ItchyQuant is a 10-point numeric rating scale to rate itch severity.
The items are scored from 0-10, where 0=no itch and 10= worst imaginable itch.
The validity of the ItchyQuant will be assessed by comparing the responses.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of harnessing an electronic platform as assessed by researcher judgement
Time Frame: 1 year from baseline
|
The feasibility of an electronic platform for instruments such that mobile technology (i.e., tablets and smartphones) can be utilized in the field to capture the data will be assessed by the researchers.
This electronic platform will be able to store and download the data both in summary format (total scores) as well as item level format, capture data across multiple time points, and deposit data into a variety of queryable databases such as spreadsheets, electronic data capture systems.
|
1 year from baseline
|
|
Prevalence of ADHD symptoms
Time Frame: Baseline
|
The prevalence of symptoms of Attention Deficit Hyperactivity Disorder (ADHD) will be assessed by the ADHD screening questionnaire.This consists of an 18-item scale and each item is scored on a 0 to 3 scale, with 0= never or rarely; 1=mild (sometimes), 2=moderate (often); 3=severe (very often).
The total score is computed as the sum of the scores on each item.
Higher scores indicate increased severity of symptoms.
|
Baseline
|
|
Prevalence of ADHD symptoms
Time Frame: 2 weeks
|
The prevalence of symptoms of Attention Deficit Hyperactivity Disorder (ADHD) will be assessed by the ADHD screening questionnaire.This consists of an 18-item scale and each item is scored on a 0 to 3 scale, with 0= never or rarely; 1=mild (sometimes), 2=moderate (often); 3=severe (very often).
The total score is computed as the sum of the scores on each item.
Higher scores indicate increased severity of symptoms.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Suephy Chen, MD, Emory University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
June 28, 2018
Study Completion (Actual)
June 28, 2018
Study Registration Dates
First Submitted
December 15, 2015
First Submitted That Met QC Criteria
January 29, 2016
First Posted (Estimate)
February 3, 2016
Study Record Updates
Last Update Posted (Actual)
August 14, 2018
Last Update Submitted That Met QC Criteria
August 11, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00081076
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pruritus
-
Ankara UniversityCompletedChronic PruritusTurkey (Türkiye)
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedChronic Kidney Disease-associated PruritusItaly
-
University of Applied Sciences of Western SwitzerlandSwiss National Science FoundationRecruitingChronic Kidney Disease Associated PruritusSwitzerland
-
Vyne Therapeutics Inc.Completed
-
Centre Hospitalier Universitaire de NiceCompleted
-
University Hospital, Basel, SwitzerlandNot yet recruitingChronic PruritusSwitzerland
-
Xiangya Hospital of Central South UniversityCompleted
-
University Hospital, BrestNot yet recruitingPruritus | Chronic Pruritus | ItchFrance
-
Johns Hopkins UniversityPfizer; Duke UniversityCompletedSkin Diseases | Pruritus | Prurigo Nodularis | Chronic Pruritus | Chronic PrurigoUnited States